CXCR4-directed endoradiotherapy with [ 177 Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia
Theranostics · 01.01.2025 · 15 (1) · 19-29
DOI: 10.7150/thno.101215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 01.01.2025. Verfasst von Krischan Braitsch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Receptors, CXCR4, Whole-Body Irradiation. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
Despite recent advances in the targeted therapy of AML, the disease continues to have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (alloSCT) remains to be the curative therapy option for fit patients with high-risk disease. Especially patients with relapsed or refractory (r/r) AML continue to have poor outcomes. Myeloablative total body irradiation (TBI) based conditioning can be used in AML patients refractory to multiple lines of standard therapy, but the optimal conditioning regimen remains unclear for patients considered to be chemotherapy- refractory. Feasibility of C-X-C-motif chemokine receptor 4 (CXCR4)-directed endoradiotherapy (ERT) has previously been demonstrated in AML patients with CXCR4 expression on leukemic blasts.
Methods
Here, we report on a small cohort of seven AML patients refractory to multiple lines (range 3-7) of therapy, who received CXCR4-directed ERT with [177Lu]Pentixather in combination with TBI and chemotherapy prior to alloSCT. We report outcomes with a focus on toxicity, engraftment, the impact on the bone marrow (BM) niche and efficacy.
Results
In this intensively pre-treated group of patients, promising response (6 out of 7 patients) and engraftment (6 out of 7 patients) rates were observed. Histopathological analysis showed that niche compartments are spared and allow for engraftment to occur despite the combined ERT and TBI conditioning.
Conclusion
To the best of our knowledge, we report on the first seven patients who received CXCR4-directed ERT in sequential combination with TBI and chemotherapy, providing an effective, individualized conditioning regimen for intensively pre-treated r/r AML patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Department of Nuclear Medicine, School of Medicine and Health, Technical University Munich, Munich, Germany.
- German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University Hospital rechts der Isar (MRI), Germany.
- Department of Radiation Oncology, School of Medicine and Health, Technical University Munich, Munich, Germany.
- Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany.
- Bavarian Cancer Research Center (BZKF), Munich, Germany.
Zitieren
APA
Braitsch, K., Lorenzini, T., Hefter, M., Koch, K., Nickel, K., Peeken, J. C., Götze, K. S., Weber, W., Allmann, A., D'Alessandria, C., Brosch-Lenz, J., Bassermann, F., Rudelius, M., Verbeek, M., Eiber, M., & Herhaus, P. (2025). CXCR4-directed endoradiotherapy with [ 177 Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia. Theranostics, 15(1), 19-29. https://doi.org/10.7150/thno.101215
Vancouver
Braitsch K, Lorenzini T, Hefter M, Koch K, Nickel K, Peeken JC, et al. CXCR4-directed endoradiotherapy with [ 177 Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia. Theranostics. 2025;15(1):19-29. doi:10.7150/thno.101215
BibTeX
@article{Braitsch2025,
author = {Braitsch, Krischan and Lorenzini, Theo and Hefter, Maike and Koch, Katrin and Nickel, Katharina and Peeken, Jan C and Götze, Katharina S and Weber, Wolfgang and Allmann, Anne and D'Alessandria, Calogero and Brosch-Lenz, Julia and Bassermann, Florian and Rudelius, Martina and Verbeek, Mareike and Eiber, Matthias and Herhaus, Peter},
title = {CXCR4-directed endoradiotherapy with [ 177 Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {1},
pages = {19--29},
doi = {10.7150/thno.101215}
}
EUVIMED